LMGF(SZ:002734)2021-04-27 16:00Revenue and Profit - Revenue for Q1 2021 was CNY 1,278,419,638.94, a decrease of 3.53% compared to CNY 1,325,240,428.99 in the same period last year[7] - Net profit attributable to shareholders increased by 12.96% to CNY 160,851,094.64 from CNY 142,400,624.33 year-on-year[7] - Basic earnings per share decreased by 14.00% to CNY 0.43 from CNY 0.50 in the same period last year[7] - The company reported a net profit attributable to shareholders increased by 12.96%, driven by a higher ownership percentage in the Weiyuan asset group[14] - Net profit for the first quarter was CNY 173,633,180.46, up from CNY 167,104,532.33 year-over-year[42] - The company reported a total comprehensive income of CNY 173,802,109.00, compared to CNY 167,480,278.72 in the previous period[43] Cash Flow - Net cash flow from operating activities was negative at CNY -368,442,247.53, a decline of 674.65% compared to CNY -47,562,155.78 in the previous year[7] - The cash flow from operating activities decreased by 674.65% due to increased cash payments for goods and services[14] - Cash inflow from operating activities totaled CNY 646,867,752.97, a decrease from CNY 786,390,300.43 in the previous period[49] - Cash outflow from operating activities was CNY 1,015,310,000.50, compared to CNY 833,952,456.21 in the prior period, leading to a net cash flow from operating activities of -CNY 368,442,247.53[50] - The company experienced a cash flow outflow from investment activities of -CNY 237,802,493.07, compared to -CNY 27,713,085.41 in the previous period[50] - The company received CNY 17,070,139.68 in tax refunds during the quarter, compared to CNY 10,686,417.12 in the previous period[49] Assets and Liabilities - Total assets increased by 16.79% to CNY 6,061,291,065.44 from CNY 5,189,717,085.51 at the end of the previous year[7] - Current assets rose to CNY 2,901,589,663.45, up from CNY 2,179,584,951.25, indicating an increase of about 33.1%[32] - Total liabilities rose to CNY 3,147,556,827.38 from CNY 2,673,643,228.49, representing an increase of about 17.7%[34] - Total equity increased to CNY 2,913,734,238.06 from CNY 2,516,073,857.02, showing a growth of approximately 15.8%[35] - The total owner's equity attributable to the parent company increased to CNY 2,753,887,027.71 from CNY 2,368,330,894.91, reflecting a growth of around 16.2%[35] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 22,777[10] - The largest shareholder, Li Ming, holds 19.79% of the shares, amounting to 73,734,050 shares[10] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Investments and Projects - The company successfully issued 980 million yuan in convertible bonds, with funds allocated to investment projects[15] - The company is in trial production for several projects, including a 500-ton benzoyl methyl ring project and a 10,000-ton series product project[15] - The construction of new green bio-product manufacturing projects has commenced[15] Financial Management - The company has established a dedicated account storage system for managing raised funds to protect the rights of minority investors[22] - The company has signed tripartite supervision agreements with multiple banks to ensure proper management of raised funds[22] - There were no violations regarding external guarantees during the reporting period[26] - The company reported no non-operating occupation of funds by controlling shareholders or related parties during the reporting period[27] Other Financial Metrics - The company’s investment income fell by 70.39% due to market fluctuations affecting a joint venture[14] - The company allocated RMB 290 million of the raised funds to supplement working capital on March 5, 2021[23] - The company approved the use of RMB 142.75 million of raised funds to replace pre-invested self-raised funds on March 26, 2021[23] - The company confirmed an investment income of RMB 2.19 million from derivative investments during the reporting period[26] - The fair value loss from derivative investments was RMB 0.7335 million, calculated based on market prices as of the balance sheet date[26]